USPTO serial 79436062
ASCELIA
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- GALLOWAY, JAMILLA ESPY
- Law office
- TMO LAW OFFICE 121
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with ASCELIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monica Riva Talley
Monica Riva Talley Attorney of Record, Virginia and Washing10th Floor1101 K Street, N.W.Washington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; chemical substances and chemical products for scientific purposes, namely, chemical products for diagnostic, chemical preparations, biological research, and pharmaceutical research and adjacent scientific purposes; biochemicals for in vitro and in vivo scientific use; chemicals for use in vitro scientific use | ACTIVE | — |
| 005 | Pharmaceuticals, medical and veterinary preparations, namely, preparations for the prevention, diagnosis, treatment, or management of medical conditions within oncology, immunology, hematology, cardiovascular, neurological, metabolic diseases and adjacent therapeutic areas including diagnostic agents, diagnostic reagents, contrast media, and contrast agents for use in medical diagnostic imaging; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; medical plasters, being materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; contrast media and contrast agents for use for in vivo imaging; contrast media and contrast agents for use for in vitro diagnostics | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design relating thereto in the field of pharmaceuticals and medical imaging; industrial analysis and research services in the field of pharmaceuticals and medical imaging; design and development of computer hardware and software; bacterological and biological research; scientific research in the nature of conducting clinical trials for others; research and development of new products for others; scientific laboratory services | ACTIVE | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings or animals; advisory and consulting services relating to medical and diagnostic products in medical and medical diagnostic examination; advisory and consulting services relating to use of contrast medical and contrast agents in medical and diagnostic examinations; advisory and consulting services relating to the use of medical diagnostic imaging and medical imaging technologies; consulting services in the field of diagnostic medical testing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ascelia Pharma AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ASCELIA
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 4, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 29, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 28, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 28, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 28, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 30, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 30, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 28, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 4, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 4, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 30, 2025 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |